Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Journal of Neurology
|
December 15, 2010
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients
Simona Malucchi, Francesca Gilli, Marzia Caldano, et al.
Journal of Neurology
|
September 23, 2024
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
Simona Malucchi, Cecilia Irene Bava, Paola Valentino, et al.
Neurology and Therapy
|
December 5, 2016
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Simona Malucchi, Marco Capobianco, Marianna Lo Re, et al.
Frontiers in Neurology
|
April 14, 2025
Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice
Diego Centonze, Alessia Di Sapio, Vincenzo Brescia Morra, et al.
Cephalalgia : an International Journal of Headache
|
April 25, 2015
The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice
Antonio Bertolotto, Maria Malentacchi, Marco Capobianco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 4, 2008
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients
Marco Capobianco, Annalisa Rizzo, Simona Malucchi, et al.
Brain, Behavior, and Immunity
|
May 26, 2026
Serum neurofilament light chain increases in healthy postpartum: is it subclinical brain damage or neuroplasticity?
Antonio Bertolotto, Paola Valentino, Cecilia Irene Bava, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2020
Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!
Eugenia Rota, Marina Grandis, Alessia Di Sapio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 10, 2025
Social determinants of health in multiple sclerosis in Italy: A scoping review
Marta Ponzano, Maurizio Mario Fedriga, Alessio Signori, et al.
Journal of Neuroimmunology
|
October 24, 2007
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies
Francesca Gilli, Fabiana Marnetto, Marzia Caldano, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Journal of Neurology
|
December 15, 2010
One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients
Simona Malucchi, Francesca Gilli, Marzia Caldano, et al.
Journal of Neurology
|
September 23, 2024
In multiple sclerosis patients a single serum neurofilament light chain (sNFL) dosage is strongly associated with 12 months outcome: data from a real-life clinical setting
Simona Malucchi, Cecilia Irene Bava, Paola Valentino, et al.
Neurology and Therapy
|
December 5, 2016
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study
Simona Malucchi, Marco Capobianco, Marianna Lo Re, et al.
Frontiers in Neurology
|
April 14, 2025
Steps toward the implementation of neurofilaments in multiple sclerosis: patient profiles to be prioritized in clinical practice
Diego Centonze, Alessia Di Sapio, Vincenzo Brescia Morra, et al.
Cephalalgia : an International Journal of Headache
|
April 25, 2015
The use of the 25 Sprotte needle markedly reduces post-dural puncture headache in routine neurological practice
Antonio Bertolotto, Maria Malentacchi, Marco Capobianco, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 4, 2008
Glatiramer acetate is a treatment option in neutralising antibodies to interferon-beta-positive patients
Marco Capobianco, Annalisa Rizzo, Simona Malucchi, et al.
Brain, Behavior, and Immunity
|
May 26, 2026
Serum neurofilament light chain increases in healthy postpartum: is it subclinical brain damage or neuroplasticity?
Antonio Bertolotto, Paola Valentino, Cecilia Irene Bava, et al.
Orphanet Journal of Rare Diseases
|
August 22, 2020
Screening for Fabry disease in unknown origin axonal polyneuropathy: to do or not to do, this is the question!
Eugenia Rota, Marina Grandis, Alessia Di Sapio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 10, 2025
Social determinants of health in multiple sclerosis in Italy: A scoping review
Marta Ponzano, Maurizio Mario Fedriga, Alessio Signori, et al.
Journal of Neuroimmunology
|
October 24, 2007
Anti-interferon-beta neutralising activity is not entirely mediated by antibodies
Francesca Gilli, Fabiana Marnetto, Marzia Caldano, et al.
Page
of 6